July 31, 2017
Onxeo Divests Two Non-Core Products in Oral Pathologies to Vectans Pharma
Media
July 28, 2017
GenSight Biologics Reports Interim Financial Results for the First Half of 2017
July 28, 2017
Onxeo Reports First-Half 2017 Results and Business Update
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 21, 2017
Exercise of over-allotment option and end of the stabilization period
July 17, 2017
Targovax ASA: Final result of the subsequent offering
